Sandbox:Maneesha: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
*It accounts for 45-75% of all salivary gland neoplasms. | *It accounts for 45-75% of all salivary gland neoplasms. | ||
===Age=== | ===Age=== | ||
* | *People of all age groups may develop Pleomorphic adenoma.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref> | ||
*The incidence of Pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years. | *The incidence of Pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years. | ||
===Race=== | ===Race=== | ||
Revision as of 20:28, 8 January 2019
Epidemiology and Demographics
Incidence
- The annual incidence of Pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population.[1]
- It accounts for 45-75% of all salivary gland neoplasms.
Age
- People of all age groups may develop Pleomorphic adenoma.[1]
- The incidence of Pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.
Race
There is no racial predilection to Pleomorphic adenoma.
Gender
- Females are predominantly affected by Pleomorphic adenoma than males. The female to male ratio is approximately (2:1)
\
References=
- ↑ 1.0 1.1 Pinkston JA, Cole P (June 1999). "Incidence rates of salivary gland tumors: results from a population-based study". Otolaryngol Head Neck Surg. 120 (6): 834–40. doi:10.1016/S0194-5998(99)70323-2.